Elekta, a world-wide supplier of clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders, has announced a global distribution agreement with Medical Intelligence (MI), a single-source supplier of high-precision patient fixation systems.
As part of the agreement, Elekta will integrate key elements of MI's radiotherapy and patient positioning systems into its own product portfolio. The agreement includes commercial distribution as well as plans for future product developments for use by clinical specialists to precisely and easily target tumor cells.
Among the products from MI is HexaPOD RTC, an image guided robotic patient positioning system that allows for sub millimeter patient positioning with six degrees of freedom (6D). 6D means that the system can correct rotational errors in patient positioning as well as translational errors, making it ideal for stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT).
HexaPOD will be available for use with all Elekta digital linear accelerator systems
In addition to positioning systems, Elekta will also distribute MI's patient immobilization devices.